官方服务：
资源简介：
ccRCC-clinical data from TCGA
应用场景：
创建时间：
2018-01-25
相关数据集
Additional file 5: of Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma
Table S4. Enriched genes in Pathways in Cancer. (XLSX 11Â kb)
DataCite Commons2024-03-25 更新60
Additional file 3 of Loss of RANBP3L leads to transformation of renal epithelial cells towards a renal clear cell carcinoma like phenotype
Additional file 3: Table S2. CRISPR Cas 9 target sites and TOPO TA results for NFAT5 Knockout cells and mouse NFAT5-KO RNA-Seq at 300 and 600 mosmol/kg
Figshare2021-07-08 更新10
Table1_FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis.XLSX
Ferredoxin 1 (FDX1), an iron-sulphur protein, is responsible for electron transfer in a range of metabolic redox reactions. Clear cell renal cell carcinoma (ccRCC) is an aggressive cancer characterise
NIAID Data Ecosystem10
YAP targets TEAD-NF-?B complex and inhibits ccRCC tumor growth
The prevalent understanding of Hippo signaling is one inhibitory pathway in tumor growth via deactivating the potential of YAP-TEAD transcriptional complex. The aberrant activation of YAP was observed
NIAID Data Ecosystem10
Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
BackgroundOvarian carcinomas consist of at least five distinct diseases: high-grade serous, low-grade serous, clear cell, endometrioid, and mucinous. Biomarker and molecular characterization may repre
Figshare2016-01-18 更新10
